• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC GUNTHER TULIP FEMORAL VENA CAVA FILTER SET; DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC GUNTHER TULIP FEMORAL VENA CAVA FILTER SET; DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR Back to Search Results
Model Number G33016
Device Problems Difficult to Remove (1528); Structural Problem (2506)
Patient Problems Vessel Or Plaque, Device Embedded In (1204); Pain (1994); Perforation of Vessels (2135); Stenosis (2263); Abdominal Cramps (2543)
Event Type  Injury  
Manufacturer Narrative
The previous medwatch report was submitted by william cook (b)(4) under manufacturer report reference# 3002808486-2020-00838.Additional information provided determined that this device was manufactured by cook inc.With the submission of this initial medwatch report, cook inc.Informs that all future submissions regarding this complaint will be handled under the manufacturer report reference # referenced in this initial medwatch report.Reporter occupation: non-healthcare professional.Investigation: the reported allegations have been investigated based on the information provided to date.Filter interacts with ivc wall, e.G.Penetration/perforation/embedment.This may be either symptomatic or asymptomatic.Potential causes may include improper deployment; and (or) excessive force or manipulations near an in-situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: trauma to adjacent structures, vascular trauma, vena cava perforation, vena cava penetration.Physician practice guidelines and published guidance from regulatory agencies recommend that patients with indwelling filters undergo routine follow-up.The risks/benefits of filter retrieval should be considered for each patient during follow-up.Once protection from pe is no longer necessary, filter retrieval should be considered.Filter retrieval should be attempted when feasible and clinically indicated.Filter retrieval is a patient-specific, clinically complex decision; the decision to remove a filter should be based on each patient¿s individual risk/benefit profile (e.G., a patient¿s continued need for protection from pe compared to their experience with and (or) ongoing risk of experiencing filter-related complications).For all retrievable ivc filters, retrieval becomes more challenging with time, and this is commonly due to encapsulation of the filter legs or hook (in a tilted filter) by tissue ingrowth.The filter is designed to be retrieved with the günther tulip vena cava filter retrieval set.It may also be retrieved with the cloversnare® vascular retriever.Cook has not performed testing to evaluate the safety or effectiveness of filter retrieval using other retrieval systems or techniques.The published clinical literature includes descriptions of alternative techniques for filter retrieval; use of these techniques varies according to physician experience, patient anatomy, and filter position.The safety or effectiveness of these alternative retrieval techniques has not been established.Specific for ¿embedded¿ a filter that is embedded in the wall of the ivc may be difficult to retrieve.For all retrievable ivc filters, retrieval becomes more challenging with time, and this is commonly due to encapsulation of the filter legs or hook (in a tilted filter) by tissue ingrowth.A total of 20 devices were manufactured in the reported lot.To date, no other complaints have been reported against the lot.The associated work order was reviewed.No related/relevant notes were documented.The device is manufactured and inspected according to current controls.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information become available.
 
Event Description
It is alleged that ¿on or about (b)(6) 2015, [pt] was implanted with a cook gunther tulip vena cava filter.In (b)(6) 2017, [pt] underwent a ct scan which revealed that the cook filter struts had moved since placement and were extending beyond the wall of her ivc.In (b)(6) 2018, [pt] underwent surgery to remove the cook filter.During the procedure, it was revealed that the cook filter was embedded in [pt]¿s inferior vena cava.The cook filter was unable to be removed and it was left in place.¿.
 
Manufacturer Narrative
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.Investigation the following allegations have been investigated: vena cava (vc) perforation, stenosis, back/inflamed pain, stomach cramps, mental anguish and continued anticoagulation.Investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.The additional information regarding vena cava perforation does not change the previous investigation results for perforation and embedment.Ivc occlusion/ thrombosis, new dvt, ivc stenosis as a reported complication, is a known risk in relation to filter implant and is well documented in the clinical literature and in clinical practice guidelines.This is supported by the clinical evidence report established to assess available clinical data to identify and evaluate the clinical safety and performance of the cook vena cava filters.Potential adverse events that may occur include, but are not limited to, the following: vena cava occlusion or thrombosis, vena cava stenosis, deep vein thrombosis.Unknown if the reported back/inflamed pain, stomach cramps, mental anguish, and continued anticoagulation are directly related to the filter and unable to identify a corresponding failure mode at this point in time.Unknown if the reported continued anticoagulation is directly related to the filter and unable to identify a corresponding failure mode at this point in time.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information becomes available.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, or that any cook device caused or contributed to or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
Patient allegedly received an implant on (b)(6) 2015 via the femoral vein due to post deep vein thrombosis (dvt).The patient alleges vena cava perforation, stenosis, embedment, unable to remove.The patient further alleges lower back pain, inflamed pain, stomach cramps, mental anguish and "continue to take blood thinners".Attempted percutaneous device removal on (b)(6) 2018 due to device failure.(b)(6) 2017, per a report from computed tomography; ¿there is no evidence of tilt of the ivc.There is no evidence of fractured strut.However, the also seen in the right posterior strut.There is no evidence of retroperitoneal hemorrhage.The aorta is of normal caliber.There is a small focus of aortic calcified plaque.At the level of the right posterior strut, which extends beyond the ivc wall, there is some remodeling of the anterior right cortex of the adjacent vertebral body approximate l2.¿ (b)(6) 2018, per a report from retrieval report (attempted); ¿at this point, the hook of the filter was noted to be deformed.At this point, several additional attempts were performed by myself along with [physician] to retrieve the filter.The snare was advanced below the hook to the base of the cap of the filter.With the filter engaged in this manner, the outer sheath was advanced over the filter and again multiple attempts to dislodge the filter from the wall of the cava were attempted, but the filter would not disengage.Eventually the snare was fractured within the sheath impression: attempts to dislodge tulip inferior vena cava filter as described above.Despite aggressive maneuvers the filter could not be dislodged from the wall, likely secondary to endothelialization of the struts of the filter.The snare was removed in totality without complication.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GUNTHER TULIP FEMORAL VENA CAVA FILTER SET
Type of Device
DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
MDR Report Key10649545
MDR Text Key210637275
Report Number1820334-2020-01824
Device Sequence Number1
Product Code DTK
UDI-Device Identifier10827002330167
UDI-Public(01)10827002330167(17)180831(10)6130592
Combination Product (y/n)N
PMA/PMN Number
K043509
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 10/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/08/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2018
Device Model NumberG33016
Device Catalogue NumberIGTCFS-65-FEM
Device Lot Number6130592
Was Device Available for Evaluation? No
Date Manufacturer Received10/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Weight100
-
-